Citigroup’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-234,308
| Closed | -$18.7M | – | 6590 |
|
|
2021
Q1 | $18.7M | Buy |
234,308
+220,220
| +1,563% | +$17.2M | 0.01% | 992 |
|
|
2020
Q4 | $1.11M | Buy |
14,088
+7,348
| +109% | +$431K | ﹤0.01% | 3437 |
|
|
2020
Q3 | $297K | Sell |
6,740
-12,043
| -64% | -$593K | ﹤0.01% | 4292 |
|
|
2020
Q2 | $831K | Buy |
18,783
+3,408
| +22% | +$127K | ﹤0.01% | 3759 |
|
|
2020
Q1 | $551K | Sell |
15,375
-12,014
| -44% | -$683K | ﹤0.01% | 3787 |
|
|
2019
Q4 | $1.94M | Buy |
27,389
+16,962
| +163% | +$1.23M | ﹤0.01% | 3014 |
|
|
2019
Q3 | $781K | Buy |
10,427
+305
| +3% | +$25.9K | ﹤0.01% | 3906 |
|
|
2019
Q2 | $816K | Sell |
10,122
-4,184
| -29% | -$294K | ﹤0.01% | 3890 |
|
|
2019
Q1 | $957K | Buy |
14,306
+11,975
| +514% | +$907K | ﹤0.01% | 3446 |
|
|
2018
Q4 | $173K | Sell |
2,331
-3,506
| -60% | -$289K | ﹤0.01% | 5161 |
|
|
2018
Q3 | $538K | Buy |
5,837
+2,779
| +91% | +$265K | ﹤0.01% | 4184 |
|
|
2018
Q2 | $301K | Sell |
3,058
-1,124
| -27% | -$126K | ﹤0.01% | 4619 |
|
|
2018
Q1 | $466K | Buy |
4,182
+1,256
| +43% | +$141K | ﹤0.01% | 4063 |
|
|
2017
Q4 | $301K | Sell |
2,926
-12,253
| -81% | -$1.22M | ﹤0.01% | 4643 |
|
|
2017
Q3 | $1.43M | Sell |
15,179
-9,670
| -39% | -$763K | ﹤0.01% | 3008 |
|
|
2017
Q2 | $1.94M | Buy |
24,849
+1,203
| +5% | +$90.4K | ﹤0.01% | 2629 |
|
|
2017
Q1 | $1.89M | Sell |
23,646
-36,549
| -61% | -$2.9M | ﹤0.01% | 2554 |
|
|
2016
Q4 | $4.74M | Buy |
60,195
+36,850
| +158% | +$2.86M | ﹤0.01% | 1895 |
|
|
2016
Q3 | $1.82M | Buy |
23,345
+12,085
| +107% | +$877K | ﹤0.01% | 2608 |
|
|
2016
Q2 | $774K | Sell |
11,260
-20,159
| -64% | -$1.39M | ﹤0.01% | 3190 |
|
|
2016
Q1 | $2.24M | Buy |
31,419
+28,250
| +891% | +$1.77M | ﹤0.01% | 2358 |
|
|
2015
Q4 | $197K | Sell |
3,169
-329
| -9% | -$20.1K | ﹤0.01% | 4757 |
|
|
2015
Q3 | $199K | Sell |
3,498
-914
| -21% | -$48.4K | ﹤0.01% | 4494 |
|
|
2015
Q2 | $237K | Sell |
4,412
-14,444
| -77% | -$703K | ﹤0.01% | 4305 |
|
|
2015
Q1 | $896K | Buy |
18,856
+1,441
| +8% | +$63.8K | ﹤0.01% | 3191 |
|
|
2014
Q4 | $753K | Sell |
17,415
-18,665
| -52% | -$763K | ﹤0.01% | 3436 |
|
|
2014
Q3 | $1.24M | Buy |
36,080
+8,095
| +29% | +$286K | ﹤0.01% | 2890 |
|
|
2014
Q2 | $1.02M | Buy |
27,985
+22,132
| +378% | +$751K | ﹤0.01% | 2961 |
|
|
2014
Q1 | $198K | Sell |
5,853
-10,693
| -65% | -$353K | ﹤0.01% | 4334 |
|
|
2013
Q4 | $561K | Buy |
16,546
+8,968
| +118% | +$311K | ﹤0.01% | 3687 |
|
|
2013
Q3 | $242K | Buy |
7,578
+991
| +15% | +$26.4K | ﹤0.01% | 4000 |
|
|
2013
Q2 | $148K | Buy |
+6,587
| New | +$143K | ﹤0.01% | 4520 |
|
Citigroup's CMD Position: Q2 2021 in Review
Citigroup sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 234,308 shares — an estimated $18.7M sold.
Citigroup first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $18.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Citigroup reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Citigroup sold 234,308 Cantel Medical Corporation shares in Q2 2021, an estimated $18.7M.
- Citigroup first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Citigroup's Cantel Medical Corporation position peaked at $18.7M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.